FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2793923842> ?p ?o ?g. }

• W2793923842 endingPage "356" @default.
• W2793923842 startingPage "343" @default.
• W2793923842 abstract "Bexarotene (Targretin®) is currently the only FDA approved retinoid X receptor (RXR) -selective agonist for the treatment of cutaneous T-cell lymphomas (CTCLs). The main side effects of bexarotene are hypothyroidism and elevation of serum triglycerides (TGs). The novel RXR ligand, 9-cis UAB30 (UAB30) does not elevate serum TGs or induce hypothyroidism in normal subjects.To assess preclinical efficacy and mechanism of action of UAB30 in the treatment of CTCLs and compare its action with bexarotene.With patient-derived CTCL cell lines, we evaluated UAB30 function in regulating growth, apoptosis, cell cycle check points, and cell cycle-related markers.Compared to bexarotene, UAB30 had lower half maximal inhibitory concentration (IC50) values and was more effective in inhibiting the G1 cell cycle checkpoint. Both rexinoids increased the stability of the cell cycle inhibitor, p27kip1 protein, in part, through targeting components involved in the ubiquitination-proteasome system: 1) decreasing SKP2, a F-box protein that binds and targets p27kip1 for degradation by 26S proteasome and 2) suppressing 20S proteasome activity (cell line-dependent) through downregulation of PSMA7, a component of the 20S proteolytic complex in 26S proteasome.UAB30 and bexarotene induce both early cell apoptosis and suppress cell proliferation. Inhibition of the G1 to S cell cycle transition by rexinoids is mediated, in part, through downregulation of SKP2 and/or 20S proteasome activity, leading to increased p27kip1 protein stability. Because UAB30 has minimal effect in elevating serum TGs and inducing hypothyroidism, it is potentially a better alternative to bexarotene for the treatment of CTCLs." @default.
• W2793923842 created "2018-03-29" @default.
• W2793923842 creator A5002361220 @default.
• W2793923842 creator A5006997027 @default.
• W2793923842 creator A5012059639 @default.
• W2793923842 creator A5017851498 @default.
• W2793923842 creator A5029623087 @default.
• W2793923842 creator A5032502592 @default.
• W2793923842 creator A5034766267 @default.
• W2793923842 creator A5038221659 @default.
• W2793923842 creator A5051982352 @default.
• W2793923842 creator A5060475091 @default.
• W2793923842 creator A5089297467 @default.
• W2793923842 date "2018-06-01" @default.
• W2793923842 modified "2023-10-17" @default.
• W2793923842 title "The retinoid X receptor agonist, 9-cis UAB30, inhibits cutaneous T-cell lymphoma proliferation through the SKP2-p27kip1 axis" @default.
• W2793923842 cites W115487351 @default.
• W2793923842 cites W13436559 @default.
• W2793923842 cites W1508632532 @default.
• W2793923842 cites W1508955993 @default.
• W2793923842 cites W1529472464 @default.
• W2793923842 cites W1558846872 @default.
• W2793923842 cites W1970779989 @default.
• W2793923842 cites W1972507334 @default.
• W2793923842 cites W1975941092 @default.
• W2793923842 cites W1980477437 @default.
• W2793923842 cites W1997391175 @default.
• W2793923842 cites W1998787622 @default.
• W2793923842 cites W2000434788 @default.
• W2793923842 cites W2000756557 @default.
• W2793923842 cites W2000953545 @default.
• W2793923842 cites W2006028933 @default.
• W2793923842 cites W2008293422 @default.
• W2793923842 cites W2011303009 @default.
• W2793923842 cites W2011466019 @default.
• W2793923842 cites W2020235979 @default.
• W2793923842 cites W2026413110 @default.
• W2793923842 cites W2032526198 @default.
• W2793923842 cites W2044057392 @default.
• W2793923842 cites W2044312503 @default.
• W2793923842 cites W2048148587 @default.
• W2793923842 cites W2055524611 @default.
• W2793923842 cites W2062161179 @default.
• W2793923842 cites W2069156114 @default.
• W2793923842 cites W2073996456 @default.
• W2793923842 cites W2089866605 @default.
• W2793923842 cites W2095296391 @default.
• W2793923842 cites W2098817749 @default.
• W2793923842 cites W2101232752 @default.
• W2793923842 cites W2102628825 @default.
• W2793923842 cites W2106608367 @default.
• W2793923842 cites W2106683936 @default.
• W2793923842 cites W2115782311 @default.
• W2793923842 cites W2116711648 @default.
• W2793923842 cites W2120756864 @default.
• W2793923842 cites W2123460401 @default.
• W2793923842 cites W2131095902 @default.
• W2793923842 cites W2144768795 @default.
• W2793923842 cites W2146644601 @default.
• W2793923842 cites W2149842546 @default.
• W2793923842 cites W2159843620 @default.
• W2793923842 cites W2160062044 @default.
• W2793923842 cites W2160356867 @default.
• W2793923842 cites W2161055005 @default.
• W2793923842 cites W2162182554 @default.
• W2793923842 cites W2210078438 @default.
• W2793923842 cites W2288832014 @default.
• W2793923842 cites W2296999234 @default.
• W2793923842 cites W2328303889 @default.
• W2793923842 cites W2484645433 @default.
• W2793923842 cites W2100103468 @default.
• W2793923842 doi "https://doi.org/10.1016/j.jdermsci.2018.03.006" @default.
• W2793923842 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6329374" @default.
• W2793923842 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29599065" @default.
• W2793923842 hasPublicationYear "2018" @default.
• W2793923842 type Work @default.
• W2793923842 sameAs 2793923842 @default.
• W2793923842 citedByCount "12" @default.
• W2793923842 countsByYear W27939238422019 @default.
• W2793923842 countsByYear W27939238422020 @default.
• W2793923842 countsByYear W27939238422021 @default.
• W2793923842 countsByYear W27939238422022 @default.
• W2793923842 countsByYear W27939238422023 @default.
• W2793923842 crossrefType "journal-article" @default.
• W2793923842 hasAuthorship W2793923842A5002361220 @default.
• W2793923842 hasAuthorship W2793923842A5006997027 @default.
• W2793923842 hasAuthorship W2793923842A5012059639 @default.
• W2793923842 hasAuthorship W2793923842A5017851498 @default.
• W2793923842 hasAuthorship W2793923842A5029623087 @default.
• W2793923842 hasAuthorship W2793923842A5032502592 @default.
• W2793923842 hasAuthorship W2793923842A5034766267 @default.
• W2793923842 hasAuthorship W2793923842A5038221659 @default.
• W2793923842 hasAuthorship W2793923842A5051982352 @default.
• W2793923842 hasAuthorship W2793923842A5060475091 @default.
• W2793923842 hasAuthorship W2793923842A5089297467 @default.
• W2793923842 hasBestOaLocation W27939238421 @default.
• W2793923842 hasConcept C104317684 @default.
• W2793923842 hasConcept C105696609 @default.

• next